Cue Biopharma Statistics
NASDAQ: CUEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.15-0.35 (-7.78%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Cue Biopharma by the numbers
Cue Biopharma has a market capitalization of $34.7 million based on 8.36M shares outstanding. With trailing EPS of $-27.80, Cue Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 80.8% below its 50-day average and 80.7% below its 200-day average.
Average daily trading volume is 567.02K shares, or about $2.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CUE valuation vs. peer median
| Metric | CUE | Peer median | Difference |
|---|---|---|---|
| Market cap | $34.69M | $33.05M | +5% |
| Avg. volume | 567.02K | 225.85K | +151% |
Peer median across 8 companies: GRCE, VERU, ATNM, HYFT, PLRX, SDEV, GRDX, FLNA.
Valuation
- Market cap
- $34.69M
- Price / sales (latest FY)
- 1.26
- EPS (TTM)
- $-27.80
- Shares outstanding
- 8.36M
Price and trading
- Previous close
- 4.50
- Open
- 4.52
- Day range
- 4.05 – 4.90
- 52-week range
- 2.83 – 45.50
- 52-week change
- -76.75%
- Beta
- —
- Volume
- 1.26M
- Average volume
- 567.02K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2025
Additional statistics
- Market Cap
- 34.69M
- Forward Pe
- -8.65
- Eps
- -27.80
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 45.50
- Week52 Low
- 2.83
- Avg Volume
- 567.02K
- Shares Outstanding
- 8.36M
- Ma50
- 21.65
- Ma200
- 21.48
- Earnings Date
- Aug 12, 2025
- Pct From52w High
- -90.88%
- Pct From52w Low
- 46.64%